Intuitive Surgical Q3 results top estimates on higher da Vinci system placements
ISRG•Intuitive Surgical reported Q3 revenue of $3.05 billion, up 22% year over year, and adjusted EPS of $3.00, beating analyst estimates of $2.91 billion and $2.64. The company repurchased $2.94 billion in shares during the quarter.
1. Q3 results
Intuitive Surgical said Q3 revenue rose 22% year over year to $3.05 billion, above the $2.91 billion analyst estimate. Adjusted EPS was $3.00, versus an estimate of $2.64; Q3 EPS was $1.49.
2. Revenue drivers and outlook
The company attributed revenue growth to increased procedure volume, higher operating lease revenue and a larger installed base of systems. Instruments and accessories revenue rose 18%, while da Vinci procedure volume grew 14% and Ion procedure volume grew 31%. For 2026, Intuitive Surgical expects da Vinci procedure growth of 14% to 15%, non-GAAP gross margin of 68.7% to 69.3% of revenue, and non-GAAP operating expense growth of 11% to 13%.
